GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » iAnthus Capital Holdings Inc (OTCPK:ITHUF) » Definitions » 3-Year RORE %

iAnthus Capital Holdings (iAnthus Capital Holdings) 3-Year RORE % : -36.57% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is iAnthus Capital Holdings 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. iAnthus Capital Holdings's 3-Year RORE % for the quarter that ended in Mar. 2024 was -36.57%.

The industry rank for iAnthus Capital Holdings's 3-Year RORE % or its related term are showing as below:

ITHUF's 3-Year RORE % is ranked worse than
80.08% of 1009 companies
in the Drug Manufacturers industry
Industry Median: 2.6 vs ITHUF: -36.57

iAnthus Capital Holdings 3-Year RORE % Historical Data

The historical data trend for iAnthus Capital Holdings's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iAnthus Capital Holdings 3-Year RORE % Chart

iAnthus Capital Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only 43.27 17.82 -35.61 -36.95 -37.37

iAnthus Capital Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.40 -33.15 -32.39 -37.37 -36.57

Competitive Comparison of iAnthus Capital Holdings's 3-Year RORE %

For the Drug Manufacturers - Specialty & Generic subindustry, iAnthus Capital Holdings's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iAnthus Capital Holdings's 3-Year RORE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, iAnthus Capital Holdings's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where iAnthus Capital Holdings's 3-Year RORE % falls into.



iAnthus Capital Holdings 3-Year RORE % Calculation

iAnthus Capital Holdings's 3-Year RORE % for the quarter that ended in Mar. 2024 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.008--0.4 )/( -1.072-0 )
=0.392/-1.072
=-36.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2024 and 3-year before.


iAnthus Capital Holdings  (OTCPK:ITHUF) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


iAnthus Capital Holdings 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of iAnthus Capital Holdings's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


iAnthus Capital Holdings (iAnthus Capital Holdings) Business Description

Traded in Other Exchanges
Address
420 Lexington Avenue, Suite 414, New York, NY, USA, 10170
iAnthus Capital Holdings Inc owns and operates licensed cannabis cultivators, processors, and dispensaries throughout the United States. The company's operating segments include the Eastern Region and Western Region. It generates a majority of its revenue from the Eastern Region. The Eastern Region includes the company's operations in Florida, Maryland, Massachusetts, New York, New Jersey, Vermont, and its CBD business. Its Western Region includes the company's operations in Arizona, Colorado, and Nevada.
Executives
Proud Richard C. Jr. director, officer: CEO and Director 8253 PARSONS PASS, NEW ALBANY OH 43054
Alexander Shoghi director SUITE 1550, 300 WEST 6TH STREET, AUSTIN TX 78701
John Alexander Paterson director 2 WENDIGO WAY, TORONTO A6 M6S2T9
Gotham Green Partners Llc 10 percent owner 1437 4TH STREET, SANTA MONICA CA 90401
Philippe Faraut officer: Chief Financial Officer 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Kenneth W Gilbert director C/O THE WENDY'S COMPANY, ONE DAVE THOMAS BLVD., DUBLIN OH 43017
Julius Kalcevich officer: Chief Financial Officer 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Robert R Galvin officer: Interim CEO and COO
Senvest Management, Llc director, 10 percent owner, other: (See Remarks) 540 MADISON AVENUE, 32ND FLOOR, NEW YORK NY 10022
Marco Dattanasio director 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Scott Herman Cohen director 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Zachary Arrick director 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Mich J Mathews-spradlin director ONE DAVE THOMAS BLVD., DUBLIN OH 43017
Oasis Investments Ii Master Fund Ltd. 10 percent owner UGLAND HOUSE PO BOX 309, GRAND CAYMAN E9 KY1-1104
Seth Fischer 10 percent owner C/O OASIS MANAGEMENT (HONG KONG) LLC, 21/F MAN YEE BUILDING, 68 DES VOEUX ROAD, CENTRAL K3